| Dr Nimae N Awantang, MD | |
|
625 W. Baldwin Rd Ste C., Panama City, FL 32405 | |
| (850) 769-6612 | |
| (850) 769-3553 |
| Full Name | Dr Nimae N Awantang |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 625 W. Baldwin Rd Ste C., Panama City, Florida |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124156468 | NPI | - | NPPES |
| 008348000 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 23996 (Florida) | Secondary |
| 207Q00000X | Family Medicine | ME113443 (Florida) | Primary |
| Entity Name | Emerald Coast Hospitalist Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144548793 PECOS PAC ID: 0547393670 Enrollment ID: O20100727000159 |
News Archive
Research published today in Nature from scientists at Huntsman Cancer Institute (HCI) at the University of Utah shows how epithelial cells naturally turn over, maintaining constant numbers between cell division and cell death.
The Wall Street Journal reports on how the 2010 health law might impact consumers' health coverage in 2013. In addition, CQ HealthBeat examines what might become of insurance exchanges if GOP presidential candidate Mitt Romney wins the election.
BioDelivery Sciences International, Inc. announced the approval by the U.S. Food and Drug Administration of a Supplemental New Drug Application (sNDA) for a new formulation of ONSOLIS (fentanyl buccal soluble film) CII for the management of breakthrough pain in patients with cancer who are opioid tolerant.
Abbott today announced the successful completion of the tender offer by its wholly owned subsidiary Amber Acquisition Inc. to purchase all of the outstanding shares of common stock of Facet Biotech.
› Verified 4 days ago
| Entity Name | Deerfield Beach Physician Services, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366100364 PECOS PAC ID: 3274928270 Enrollment ID: O20220520002459 |
News Archive
Research published today in Nature from scientists at Huntsman Cancer Institute (HCI) at the University of Utah shows how epithelial cells naturally turn over, maintaining constant numbers between cell division and cell death.
The Wall Street Journal reports on how the 2010 health law might impact consumers' health coverage in 2013. In addition, CQ HealthBeat examines what might become of insurance exchanges if GOP presidential candidate Mitt Romney wins the election.
BioDelivery Sciences International, Inc. announced the approval by the U.S. Food and Drug Administration of a Supplemental New Drug Application (sNDA) for a new formulation of ONSOLIS (fentanyl buccal soluble film) CII for the management of breakthrough pain in patients with cancer who are opioid tolerant.
Abbott today announced the successful completion of the tender offer by its wholly owned subsidiary Amber Acquisition Inc. to purchase all of the outstanding shares of common stock of Facet Biotech.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nimae N Awantang, MD 1702 Ohio Ave, Lynn Haven, FL 32444 Ph: (850) 571-5844 | Dr Nimae N Awantang, MD 625 W. Baldwin Rd Ste C., Panama City, FL 32405 Ph: (850) 769-6612 |
News Archive
Research published today in Nature from scientists at Huntsman Cancer Institute (HCI) at the University of Utah shows how epithelial cells naturally turn over, maintaining constant numbers between cell division and cell death.
The Wall Street Journal reports on how the 2010 health law might impact consumers' health coverage in 2013. In addition, CQ HealthBeat examines what might become of insurance exchanges if GOP presidential candidate Mitt Romney wins the election.
BioDelivery Sciences International, Inc. announced the approval by the U.S. Food and Drug Administration of a Supplemental New Drug Application (sNDA) for a new formulation of ONSOLIS (fentanyl buccal soluble film) CII for the management of breakthrough pain in patients with cancer who are opioid tolerant.
Abbott today announced the successful completion of the tender offer by its wholly owned subsidiary Amber Acquisition Inc. to purchase all of the outstanding shares of common stock of Facet Biotech.
› Verified 4 days ago
Saul A Verazain, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2306 Martin Luther King Jr Blvd, Panama City, FL 32405 Phone: 850-763-9744 Fax: 850-785-2020 | |
Jeannie Farris, APRN Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2202 State Ave Ste 201, Panama City, FL 32405 Phone: 850-785-0029 Fax: 850-785-7600 | |
Cassandra Pierce, FNP-C Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1514 W 23rd St, Panama City, FL 32405 Phone: 850-481-1101 Fax: 850-640-3949 | |
Isabel Maria Parris-ramie, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2101 Northside Dr Unit 702, Panama City, FL 32405 Phone: 850-785-0040 Fax: 850-785-5717 | |
Albert F Mapp Jr., MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 489 N Tyndall Pkwy, Panama City, FL 32404 Phone: 850-763-5689 Fax: 850-913-8046 | |
Dr. Thomas Woodrow Smith Jr., M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 425 W 19th St, Panama City, FL 32405 Phone: 850-344-1433 | |
Dr. Keith B Banton, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1937 Harrison Ave, Panama City, FL 32405 Phone: 850-763-4700 Fax: 850-763-4999 |